These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 5778117)
41. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria. Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890 [TBL] [Abstract][Full Text] [Related]
42. Plasma prolactin in normal and hypertensive subjects: relationships with age, posture, blood pressure, catecholamines, and renin. Meier A; Weidmann P; Hennes U; Ziegler WH J Clin Endocrinol Metab; 1980 Feb; 50(2):304-8. PubMed ID: 6986395 [No Abstract] [Full Text] [Related]
43. Enhancement of lymphocyte production by adrenocortical inhibition. Morales A; Jalali S; Garvie WH J Surg Res; 1972 Jul; 13(1):47-50. PubMed ID: 5055804 [No Abstract] [Full Text] [Related]
44. [Saralasin in subjects with low renin arterial hypertension]. Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464 [TBL] [Abstract][Full Text] [Related]
45. The natriuretic response to acute saline loading in normotensive and hypertensive renal transplant recipients. Mimran A; Mourad G; Mion CM J Hypertens Suppl; 1983 Dec; 1(2):55-7. PubMed ID: 6400118 [TBL] [Abstract][Full Text] [Related]
46. Studies on the rapid cholesterol-depleting and steroidogenic actions of luteinizing hormone in the rat ovary: effects of aminoglutethimide phosphate. Berhman HR; Armstrong DT; Greep RO Can J Biochem; 1970 Aug; 48(8):881-4. PubMed ID: 5452725 [No Abstract] [Full Text] [Related]
47. [Renin activity in arterial hypertension]. Kedrowa S; Kedra M; Klamut M; Wazny M; Woźniak K; Zminkowska U; Rześniowiecka G Pol Tyg Lek; 1972 Mar; 27(10):368-71. PubMed ID: 5018942 [No Abstract] [Full Text] [Related]
48. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension. Azizi M; Guyene TT; Chatellier G; Ménard J J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166 [TBL] [Abstract][Full Text] [Related]
49. Failure to detect excessive stress-induced adrenal corticosterone secretion following amino-glutethimide withdrawal in the rat. Greer MA; Allen CF Endocrinology; 1972 Aug; 91(2):600-2. PubMed ID: 4644238 [No Abstract] [Full Text] [Related]
50. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients. Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973 [TBL] [Abstract][Full Text] [Related]
51. [Longitudinal studies in essential hypertensive patients with low plasma renin activity]. Esch I; Placheta P; Gaul G; Kneussel K Wien Klin Wochenschr; 1973 Sep; 85(38):617-21. PubMed ID: 4752255 [No Abstract] [Full Text] [Related]
52. [Effect of changes of posture, beta-blocking agents and the cold pressure test on the levels of plasma renin activity (PRA) in essential hypertension with low serum renin]. Del Guercio R; Gentile S; Saponara A; De Buono AF Clin Ter; 1980 Sep; 94(6):627-34. PubMed ID: 6109590 [No Abstract] [Full Text] [Related]
53. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
54. [Labile hypertension: hormonal characteristic and implications of the "second messenger"]. Kuchel O; Cuche JL; Hamet P; Barbeau A; Boucher R; Genest J Union Med Can; 1973 Dec; 102(12):2458-70. PubMed ID: 4359087 [No Abstract] [Full Text] [Related]
55. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension. Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544 [TBL] [Abstract][Full Text] [Related]
56. [Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)]. Werning C Med Klin; 1973 Nov; 68(47):1559-63. PubMed ID: 4781097 [No Abstract] [Full Text] [Related]
57. Significance of plasma renin estimation in hypertensive patients. Kokot F; Kuska J Acta Med Pol; 1976; 17(1):71-7. PubMed ID: 1258693 [No Abstract] [Full Text] [Related]
58. [Arterial hypertension in patients on chronic hemodialysis]. Zogović J; Mladenović Lj Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857 [TBL] [Abstract][Full Text] [Related]
59. [Long-term effects of nifedipine on blood pressure, cardiac dynamics, and plasma renin activity in patients with essential hypertension]. Nakamura Y; Higaki S; Imazeki Y; Nakamura M; Imai H; Inagaki Y Kokyu To Junkan; 1983 May; 31(5):549-61. PubMed ID: 6356263 [No Abstract] [Full Text] [Related]
60. Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity. Dall'Asta C; Vedani P; Manunta P; Pizzocri P; Marchi M; Paganelli M; Folli F; Pontiroli AE Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):110-4. PubMed ID: 18718746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]